Indaptus Therapeutics logo

Indaptus Therapeutics Share Price (NASDAQ: INDP)

$6.49

0.1

(1.56%)

Last updated on

Check the interactive Indaptus Therapeutics Stock chart to analyse performance

Indaptus Therapeutics stock performance

as on August 30, 2025 at 1:25 am IST

  • Today's Low:$6.49
    Today's High:$6.49

    Day's Volatility :0.0%

  • 52 Weeks Low:$6.26
    52 Weeks High:$58.24

    52 Weeks Volatility :89.26%

Indaptus Therapeutics Stock Returns

PeriodIndaptus Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-31.91%
3.6%
0.0%
6 Months
-70.36%
-7.7%
0.0%
1 Year
-85.24%
-12.6%
0.0%
3 Years
-90.77%
9.5%
-4.7%

Indaptus Therapeutics Inc Key Stats

Check Indaptus Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.39
Open
$6.49
Today's High
$6.49
Today's Low
$6.49
Market Capitalization
$7.1M
Today's Volume
$4.5K
52 Week High
$58.24
52 Week Low
$6.255
Revenue TTM
$0.0
EBITDA
$-16.3M
Earnings Per Share (EPS)
$-37.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-755.04%

Stock Returns calculator for Indaptus Therapeutics Stock including INR - Dollar returns

The Indaptus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Indaptus Therapeutics investment value today

Current value as on today

₹19,353

Returns

₹80,647

(-80.65%)

Returns from Indaptus Therapeutics Stock

₹85,931 (-85.93%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Indaptus Therapeutics Stock

-44%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Indaptus Therapeutics Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Indaptus Therapeutics Inc

  • Name

    Holdings %

  • Geode Capital Management, LLC

    0.40%

  • Renaissance Technologies Corp

    0.09%

  • State Street Corp

    0.04%

  • Virtu Financial LLC

    0.04%

  • SBI Securities Co Ltd

    0.01%

  • Tower Research Capital LLC

    0.01%

Analyst Recommendation on Indaptus Therapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Indaptus Therapeutics(by analysts ranked 0 to 5 stars)

Indaptus Therapeutics Share Price Target

What analysts predicted

Upside of 285.21%

Target:

$25.00

Current:

$6.49

Indaptus Therapeutics share price target is $25.00, a slight Upside of 285.21% compared to current price of $6.49 as per analysts' prediction.

Indaptus Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, INDP stock has moved down by -11.7%
  • INDP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 155.8%
  • INDP vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 203.2%

Indaptus Therapeutics Technicals Summary

Sell

Neutral

Buy

Indaptus Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Indaptus Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Indaptus Therapeutics Inc logo
-11.1%
-70.36%
-85.24%
-90.77%
-72.03%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Indaptus Therapeutics Inc

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Organization
Indaptus Therapeutics
Employees
7
CEO
Mr. Jeffrey A. Meckler J.D.
Industry
Healthcare

Key Management of Indaptus Therapeutics Inc

NameTitle
Mr. Jeffrey A. Meckler J.D.
CEO & Director
Dr. Michael J. Newman Ph.D.
Founder, Chief Scientific Officer & Director
Mr. Walt Addison Linscott Esq.
Chief Operating Officer
Dr. Roger J. Waltzman M.B.A., M.D.
Chief Medical Officer
Mr. Nir Sassi
CFO, Secretary & Treasurer

Important FAQs about investing in INDP Stock from India :

What is Indaptus Therapeutics share price today?

Indaptus Therapeutics share price today is $6.49 as on at the close of the market. Indaptus Therapeutics share today touched a day high of $6.49 and a low of $6.49.

What is the 52 week high and 52 week low for Indaptus Therapeutics share?

Indaptus Therapeutics share touched a 52 week high of $58.24 and a 52 week low of $6.26. Indaptus Therapeutics stock price today i.e. is closed at $6.49, lower by 88.86% versus the 52 week high.

How to invest in Indaptus Therapeutics Stock (INDP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Indaptus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indaptus Therapeutics Shares that will get you 0.2311 shares as per Indaptus Therapeutics share price of $6.49 per share as on August 30, 2025 at 1:25 am IST.

What is the minimum amount required to buy Indaptus Therapeutics Stock (INDP) from India?

Indian investors can start investing in Indaptus Therapeutics (INDP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Indaptus Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Indaptus Therapeutics share’s latest price of $6.49 as on August 30, 2025 at 1:25 am IST, you will get 1.5408 shares of Indaptus Therapeutics. Learn more about fractional shares .

What are the returns that Indaptus Therapeutics has given to Indian investors in the last 5 years?

Indaptus Therapeutics stock has given -72.03% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?